Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Feasibility Study: A Safety Evaluation of RheOx on Patients With Chronic Bronchitis in the United States

NCT03631472 is registered in ClinicalTrials.gov with Gala Therapeutics, Inc. as lead sponsor.

NCT NCT03631472
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03631472 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Feasibility Study: A Safety Evaluation of RheOx on Patients With Chronic Bronchitis in the United States
Lead sponsor
Gala Therapeutics, Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
July 6, 2018
Completion date
December 30, 2024
Enrollment
21 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

chronic bronchitis, copd bronchitis